Weijing Sun, MD, discusses a major topic in locally advanced gastroesophageal junction adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
Weijing Sun, MD, gastrointestinal oncologist at the University of Kansas School of Medicine, discusses a major topic in locally advanced gastroesophageal junction (GEJ) adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
At the conference, experts debated the role of radiation therapy in this patient population, Sun says. Two studies looked at different preoperative therapy options with encouraging data both with and without radiation.
The FLOT study explored a regimen of fluorouracil, leucovorin, oxaliplatin, and docetaxel for this patient population, without radiation. The CROSS study looked at the combination of carboplatin and paclitaxel with radiation.
UGN-101 Shows Promise for Upper Tract Urothelial Cancer Durability
May 5th 2024Maintenance UGN-101 therapy demonstrated good durability of response in initial responders with low-grade upper tract urothelial cancer, as evidenced by a low rate of disease progression in a multicenter, longitudinal follow-up study.
Read More